| Jan 12, 2026 |
Jan 14, 2026 |
GUDONIS PAUL R
|
CEO |
Neutral |
67.5
|
+11,637
|
0.93%
|
✗
|
- |
| Jan 12, 2026 |
Jan 14, 2026 |
HENRY DAVID A
|
CFO |
Neutral |
77.5
|
+8,727
|
2.04%
|
✗
|
- |
| Nov 20, 2025 |
Nov 24, 2025 |
KIRK THOMAS F
|
Director |
Buy |
77.5
|
+7,437
|
1.57%
|
✗
|
$5.4K |
| Nov 18, 2025 |
Nov 21, 2025 |
Crowley Thomas Aloysius Jr.
|
Director |
Buy |
85.0
|
+4,385
|
6.10%
|
✗
|
$3.2K |
| Sep 9, 2025 |
Sep 11, 2025 |
GUDONIS PAUL R
|
CEO |
Neutral |
37.5
|
-10,000
|
-0.79%
|
✗
|
- |
| Aug 25, 2025 |
Aug 26, 2025 |
KIRK THOMAS F
|
Director |
Buy |
95.0
|
+50,000
|
11.78%
|
✗
|
$57.5K |
| Aug 18, 2025 |
Aug 19, 2025 |
KIRK THOMAS F
|
Director |
Buy |
95.0
|
+50,000
|
13.35%
|
✗
|
$55K |
| Aug 15, 2025 |
Aug 18, 2025 |
GUDONIS PAUL R
|
CEO |
Buy |
83.8
|
+50,000
|
4.14%
|
✗
|
$47.3K |
| Jun 30, 2025 |
Jul 2, 2025 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
26.3
|
-13,054
|
-8.49%
|
✗
|
$28.6K |
| Jun 30, 2025 |
Jul 2, 2025 |
HENRY DAVID A
|
CFO |
Sell |
22.5
|
-23,587
|
-5.22%
|
✗
|
$51.7K |
| Jun 11, 2025 |
Jun 13, 2025 |
Kovelman Harry
|
Chief Medical Officer |
Neutral |
90.0
|
+62,938
|
69.37%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Mitchell Micah
|
Chief Commercial Officer |
Neutral |
90.0
|
+59,440
|
42.38%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
HENRY DAVID A
|
CFO |
Neutral |
90.0
|
+76,398
|
20.37%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
GUDONIS PAUL R
|
CEO |
Neutral |
90.0
|
+157,342
|
14.96%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
KIRK THOMAS F
|
Director |
Neutral |
85.0
|
+29,720
|
8.62%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Crowley Thomas Aloysius Jr.
|
Director |
Neutral |
90.0
|
+29,720
|
70.71%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Morris Milton Mayo
|
Director |
Neutral |
90.0
|
+29,720
|
25.85%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Getz Heather C
|
Director |
Neutral |
90.0
|
+29,720
|
246.97%
|
✗
|
- |
| Jun 6, 2025 |
Jun 6, 2025 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
26.3
|
-5,743
|
-5.95%
|
✗
|
$17.1K |
| Jun 6, 2025 |
Jun 6, 2025 |
HENRY DAVID A
|
CFO |
Sell |
26.3
|
-8,373
|
-2.18%
|
✗
|
$24.9K |
| May 14, 2025 |
May 15, 2025 |
KIRK THOMAS F
|
Director |
Buy |
95.0
|
+38,767
|
12.67%
|
✗
|
$126K |
| May 15, 2025 |
May 15, 2025 |
GUDONIS PAUL R
|
CEO |
Buy |
87.5
|
+30,000
|
2.94%
|
✗
|
$96.6K |
| May 12, 2025 |
May 14, 2025 |
KIRK THOMAS F
|
Director |
Buy |
95.0
|
+50,000
|
19.54%
|
✗
|
$167.5K |
| Mar 14, 2025 |
Mar 21, 2025 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
22.5
|
-48,000
|
-25.50%
|
✗
|
$247.6K |
| Mar 13, 2025 |
Mar 14, 2025 |
KIRK THOMAS F
|
Director |
Buy |
83.8
|
+7,400
|
2.98%
|
✗
|
$37K |
| Mar 14, 2025 |
Mar 14, 2025 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
22.5
|
-48,000
|
-25.45%
|
✗
|
$247.6K |
| Mar 14, 2025 |
Mar 14, 2025 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
22.5
|
-48,000
|
-25.45%
|
✗
|
$247.6K |
| Mar 11, 2025 |
Mar 14, 2025 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
77.5
|
+2,454
|
1.32%
|
✗
|
$6.7K |
| Mar 11, 2025 |
Mar 13, 2025 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
22.5
|
-27,943
|
-22.46%
|
✗
|
$172.8K |
| Mar 11, 2025 |
Mar 13, 2025 |
GUDONIS PAUL R
|
CEO |
Neutral |
67.5
|
+6,708
|
0.66%
|
✗
|
- |
| Mar 11, 2025 |
Mar 13, 2025 |
HENRY DAVID A
|
CFO |
Sell |
68.8
|
+2,087
|
0.55%
|
✗
|
$10.5K |
| Mar 11, 2024 |
Mar 13, 2025 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
77.5
|
+2,454
|
1.32%
|
✗
|
$6.7K |
| Feb 13, 2025 |
Feb 18, 2025 |
GUDONIS PAUL R
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2024 |
Jan 24, 2025 |
Mitchell Micah
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2024 |
Jan 24, 2025 |
HENRY DAVID A
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2024 |
Jan 24, 2025 |
Kovelman Harry
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2024 |
Jan 24, 2025 |
GUDONIS PAUL R
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jan 22, 2025 |
GUDONIS PAUL R
|
CEO |
Neutral |
90.0
|
+130,000
|
14.80%
|
✗
|
- |
| Nov 4, 2024 |
Nov 5, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-121
|
-0.10%
|
✗
|
$447.7 |
| Oct 3, 2024 |
Oct 4, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-121
|
-0.10%
|
✗
|
$467.1 |
| Sep 5, 2024 |
Sep 9, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
26.3
|
-6,700
|
-5.14%
|
✗
|
$25.2K |
| Sep 3, 2024 |
Sep 5, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
27.5
|
-2,168
|
-1.64%
|
✗
|
$8.7K |
| Aug 5, 2024 |
Aug 7, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-128
|
-0.10%
|
✗
|
$506.9 |
| Jul 3, 2024 |
Jul 8, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-121
|
-0.09%
|
✗
|
$344.9 |
| Jun 10, 2024 |
Jul 2, 2024 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
26.3
|
-6,837
|
-3.31%
|
✗
|
$23.1K |
| Jun 10, 2024 |
Jul 2, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
26.3
|
-5,347
|
-3.54%
|
✗
|
$18.1K |
| Jul 1, 2024 |
Jul 2, 2024 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
26.3
|
-15,500
|
-7.77%
|
✗
|
$46.8K |
| Jul 1, 2024 |
Jul 2, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
26.3
|
-12,868
|
-8.84%
|
✗
|
$38.9K |
| Jul 1, 2024 |
Jul 2, 2024 |
HENRY DAVID A
|
CFO |
Sell |
22.5
|
-25,436
|
-6.30%
|
✗
|
$76.8K |
| Jun 10, 2024 |
Jun 12, 2024 |
HENRY DAVID A
|
CFO |
Sell |
26.3
|
-10,620
|
-2.56%
|
✗
|
$35.9K |
| Jun 10, 2024 |
Jun 12, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Buy |
83.8
|
+5,347
|
3.81%
|
✗
|
$18.1K |
| Jun 10, 2024 |
Jun 12, 2024 |
Mitchell Micah
|
Chief Commercial Officer |
Buy |
83.8
|
+6,837
|
3.55%
|
✗
|
$23.1K |
| Jun 5, 2024 |
Jun 7, 2024 |
HENRY DAVID A
|
CFO |
Neutral |
90.0
|
+70,000
|
20.32%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Mitchell Micah
|
Chief Commercial Officer |
Neutral |
90.0
|
+50,000
|
31.96%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Neutral |
90.0
|
+53,000
|
54.14%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
GUDONIS PAUL R
|
CEO |
Neutral |
90.0
|
+130,000
|
15.67%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
KIRK THOMAS F
|
Director |
Neutral |
85.0
|
+12,034
|
5.09%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Morris Milton Mayo
|
Director |
Neutral |
90.0
|
+12,034
|
11.69%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Crowley Thomas Aloysius Jr.
|
Director |
Neutral |
90.0
|
+12,034
|
40.12%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Getz Heather C
|
Director |
Neutral |
90.0
|
+12,034
|
100.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Knapp Amy K.
|
Director |
Neutral |
90.0
|
+12,034
|
15.12%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-121
|
-0.12%
|
✗
|
$421.1 |
| May 29, 2024 |
May 31, 2024 |
KIRK THOMAS F
|
Director |
Buy |
95.0
|
+50,000
|
26.81%
|
✗
|
$175K |
| May 15, 2024 |
May 17, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
22.5
|
-35,426
|
-26.55%
|
✗
|
$130.8K |
| May 3, 2024 |
May 6, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-146
|
-0.11%
|
✗
|
$560.6 |
| Apr 3, 2024 |
Apr 4, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-146
|
-0.11%
|
✗
|
$433.6 |
|
Mar 28, 2024 |
Getz Heather C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2024 |
Mar 18, 2024 |
KIRK THOMAS F
|
Director |
Buy |
95.0
|
+50,000
|
36.63%
|
✗
|
$175K |
| Mar 11, 2024 |
Mar 13, 2024 |
HENRY DAVID A
|
CFO |
Sell |
26.3
|
-7,774
|
-2.21%
|
✗
|
$27.3K |
| Mar 11, 2024 |
Mar 13, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
26.3
|
-6,590
|
-4.70%
|
✗
|
$23.1K |
| Mar 11, 2024 |
Mar 13, 2024 |
Mitchell Micah
|
Chief Commercial Officer |
Sell |
26.3
|
-5,359
|
-3.31%
|
✗
|
$18.8K |
| Mar 5, 2024 |
Mar 6, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-147
|
-0.10%
|
✗
|
$570.4 |
| Feb 5, 2024 |
Feb 5, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-146
|
-0.10%
|
✗
|
$468.7 |
| Jan 19, 2024 |
Jan 22, 2024 |
Morris Milton Mayo
|
Director |
Neutral |
90.0
|
+25,000
|
32.08%
|
✗
|
- |
| Aug 29, 2023 |
Jan 12, 2024 |
HENRY DAVID A
|
CFO |
Neutral |
90.0
|
+41,666
|
13.42%
|
✗
|
- |
| Aug 29, 2023 |
Jan 12, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Neutral |
85.0
|
+8,333
|
5.90%
|
✗
|
- |
| Jan 3, 2024 |
Jan 4, 2024 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-145
|
-0.10%
|
✗
|
$680.1 |
| Nov 20, 2023 |
Dec 14, 2023 |
KIRK THOMAS F
|
Director |
Buy |
95.0
|
+50,000
|
57.80%
|
✗
|
$155K |
| Dec 8, 2023 |
Dec 8, 2023 |
Crowley Thomas Aloysius Jr.
|
Director |
Neutral |
27.5
|
-14,997
|
-33.33%
|
✗
|
- |
| Dec 1, 2023 |
Dec 5, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
27.5
|
-8,432
|
-5.65%
|
✗
|
$398 |
| Nov 28, 2023 |
Nov 30, 2023 |
Crowley Thomas Aloysius Jr.
|
Director |
Neutral |
27.5
|
-14,997
|
-25.00%
|
✗
|
- |
| Nov 6, 2023 |
Nov 6, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-121
|
-0.08%
|
✗
|
$170.6 |
| Oct 3, 2023 |
Oct 3, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-123
|
-0.08%
|
✗
|
$135.3 |
| Sep 8, 2023 |
Sep 11, 2023 |
Morris Milton Mayo
|
Director |
Buy |
91.3
|
+15,000
|
23.83%
|
✗
|
$15.9K |
| Sep 5, 2023 |
Sep 6, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-125
|
-0.08%
|
✗
|
$108.8 |
| Aug 30, 2023 |
Aug 31, 2023 |
GUDONIS PAUL R
|
CEO |
Buy |
86.3
|
+48,400
|
5.83%
|
✗
|
$36K |
| Aug 29, 2023 |
Aug 30, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Buy |
85.0
|
+8,333
|
5.90%
|
✗
|
$5K |
| Aug 29, 2023 |
Aug 30, 2023 |
HENRY DAVID A
|
CFO |
Buy |
91.3
|
+41,666
|
13.42%
|
✗
|
$25K |
| Aug 28, 2023 |
Aug 30, 2023 |
GUDONIS PAUL R
|
CEO |
Buy |
95.0
|
+79,500
|
10.60%
|
✗
|
$60.6K |
| Aug 3, 2023 |
Aug 3, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Sell |
52.5
|
-125
|
-0.09%
|
✗
|
$88.8 |
| Jul 5, 2023 |
Jul 5, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Buy |
55.0
|
+109
|
0.08%
|
✗
|
$65.4 |
| Jun 28, 2023 |
Jun 30, 2023 |
Mitchell Micah
|
Chief Commerical Officer |
Neutral |
90.0
|
+80,000
|
97.81%
|
✗
|
- |
| Jun 28, 2023 |
Jun 30, 2023 |
Kovelman Harry
|
Chief Medical Officer |
Neutral |
90.0
|
+80,000
|
130.17%
|
✗
|
- |
| Jun 28, 2023 |
Jun 30, 2023 |
HENRY DAVID A
|
CFO |
Neutral |
90.0
|
+130,000
|
72.01%
|
✗
|
- |
| Jun 28, 2023 |
Jun 30, 2023 |
GUDONIS PAUL R
|
CEO |
Neutral |
90.0
|
+250,000
|
49.97%
|
✗
|
- |
| Jun 28, 2023 |
Jun 30, 2023 |
Morris Milton Mayo
|
Director |
Neutral |
90.0
|
+59,988
|
2036.94%
|
✗
|
- |
| Jun 28, 2023 |
Jun 30, 2023 |
Knapp Amy K.
|
Director |
Neutral |
90.0
|
+59,988
|
305.70%
|
✗
|
- |
| Jun 28, 2023 |
Jun 30, 2023 |
KIRK THOMAS F
|
Director |
Neutral |
90.0
|
+59,988
|
226.28%
|
✗
|
- |
| Jun 28, 2023 |
Jun 30, 2023 |
Crowley Thomas Aloysius Jr.
|
Director |
Neutral |
90.0
|
+59,988
|
100.00%
|
✗
|
- |
| Jun 6, 2022 |
Jun 30, 2023 |
Crowley Thomas Aloysius Jr.
|
Director |
Sell |
26.3
|
-12,901
|
-100.00%
|
✗
|
$27K |